Trading of unit rights in Scandinavian ChemoTech's ongoing issue is extended
Due to an incorrectly reported end date from Certified Adviser to Nasdaq, the trading of unit rights in Scandinavian ChemoTech's ongoing issue will be extended by one day compared to the date communicated in the prospectus. Thus, the last trading day for unit rights will be today, October 19, 2022.For more information, please contact: Mohan Frick, CEO +46 (0)10-218 93 00 ir@chemotech.se Certified Adviser: Erik Penser Bank, Tel: Corporate Finance AB, Tel: +46 8-463 80 00, E-mail: certifiedadviser@penser.se Scandinavian ChemoTech AB (publ)ChemoTech is a